German publisher JUVE has named Gleiss Lutz “Law Firm of the Year for Healthcare and Pharmaceuticals 2011”. JUVE’s choice is based on a survey among clients, competitors, young professionals and judges. Legal expertise, company strategy, but also commitment to service and practices’ future potential all play a role in the decision.
Established ten years ago, Gleiss Lutz’ healthcare & life sciences focus group was involved in numerous key cases in the healthcare industry over the past year. The practice was able to consolidate its leading market position, for example by advising the AOK Bundesverband on the German Act on the Reorganization of the Pharmaceutical Market in the Public Health Insurance (AMNOG) or representing statutory health insurance companies on allegations of collusion in connection with the collection of additional contributions. Gleiss Lutz also regularly represents major pharmaceuticals companies in patent-related disputes.
In complex cases and transactional matters, in particular, clients benefit from the firm’s full-service approach: The healthcare & life sciences focus group brings together profound industry expertise and specialist knowledge from a wide range of related areas, such as medical, healthcare, hospitals and medical practitioners as well as IP, public procurement, antitrust and data protection.
Gleiss Lutz was already “International Firm of the Year 2011” earlier this year by London-based Legal Business.
Forward
